Continuous glucose monitoring may lower mortality risk in diabetic patients on insulin

People with benignant 2 diabetes (T2D) who began utilizing continuous glucose monitoring (CGM) portion receiving basal insulin had a 44% little hazard of dying from immoderate origin aft 1 twelvemonth than those who did not usage CGM, according to an investigation of diligent information being presented astatine the yearly gathering of the European Association for the Study of Diabetes (EASD) successful Milan, Italy, Sept. 28–Oct. 2. After 2 years, their hazard was 35% lower.